Cholinergic neurons in the basal forebrain of aged female mice

Giedrius Kalesnykas1, Jukka Puoliväli, Jouni Sirviö

  • 1Department of Neuroscience and Neurology, University of Kuopio, P.O. Box 1627, Kuopio FIN-70211, Finland.

Brain Research
|September 9, 2004
PubMed

Insights

Aging female mice show that estrogen receptor alpha (ERalpha) in basal forebrain cholinergic neurons can still respond to estrogen changes. This suggests potential for therapies targeting elderly individuals.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Aging Research

Background:

  • Aging impairs cellular functions and signal responsiveness.
  • Pharmacological treatments may be less effective in aged organisms.
  • Estrogen plays a role in neuronal function.

Purpose of the Study:

  • Investigate the response of basal forebrain cholinergic neurons and estrogen receptor alpha (ERalpha) to estrogen availability in aged female mice.
  • Determine if aged cholinergic neurons maintain sensitivity to estrogen.
  • Explore region-specific responses within the basal forebrain.

Main Methods:

  • Adult female mice (18 months old) underwent sham surgery, ovariectomy, or ovariectomy with 17beta-estradiol treatment.
  • Three months post-surgery, brain tissues were collected.
  • Double immunostaining for choline acetyltransferase (ChAT) and ERalpha was performed.
  • Stereological cell counting quantified ChAT-immunoreactive (ir) neurons and ERalpha co-localization.

Main Results:

  • Estrogen level changes did not affect the total number of ChAT-ir neurons in the basal forebrain.
  • The percentage of ChAT-ir neurons expressing ERalpha-ir was significantly higher in ovariectomized mice compared to sham-operated or estrogen-treated mice.
  • This effect was specific to the medial septum and vertical diagonal band of Broca.

Conclusions:

  • Basal forebrain cholinergic neurons expressing ERalpha in aged female mice retain the ability to respond to altered estrogen levels.
  • The response is region-specific within the basal forebrain.
  • These findings are relevant for developing age-specific therapeutic strategies.

Related Concept Videos

Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...